Glaukos Lands $29,500,003 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    26051 Merit Circle Laguna Hills, CA 92653
  • Company Description
    Glaukos is creating a new class of micro-bypass therapies to achieve sustainable, target intraocular pressures through the restoration of physiologic outflow, reduce the challenges and risks of glaucoma management associated with traditional therapies, and aid in the preservation of vision.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy